| 000 | 01644 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515175908.0 | ||
| 264 | 0 | _c20090820 | |
| 008 | 200908s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2009.06.135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShin, Niu | |
| 245 | 0 | 0 |
_aPharmacological characterization of INCB3344, a small molecule antagonist of human CCR2. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cSep 2009 |
||
| 300 |
_a251-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBiological Assay |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChemokine CCL2 _xmetabolism |
| 650 | 0 | 4 | _aChemotaxis |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xmetabolism |
| 650 | 0 | 4 |
_aFlow Cytometry _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPyrrolidines _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, CCR2 _xantagonists & inhibitors |
| 700 | 1 | _aBaribaud, Frédéric | |
| 700 | 1 | _aWang, Kathy | |
| 700 | 1 | _aYang, Genjie | |
| 700 | 1 | _aWynn, Rich | |
| 700 | 1 | _aCovington, Maryanne B | |
| 700 | 1 | _aFeldman, Patricia | |
| 700 | 1 | _aGallagher, Karen B | |
| 700 | 1 | _aLeffet, Lynn M | |
| 700 | 1 | _aLo, Yvonne Y | |
| 700 | 1 | _aWang, Anlai | |
| 700 | 1 | _aXue, Chu-Biao | |
| 700 | 1 | _aNewton, Robert C | |
| 700 | 1 | _aScherle, Peggy A | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 387 _gno. 2 _gp. 251-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2009.06.135 _zAvailable from publisher's website |
| 999 |
_c18992087 _d18992087 |
||